Federated Hermes’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.7K | Buy |
2,645
+2,344
| +779% | +$26.3K | ﹤0.01% | 1680 |
|
|
2025
Q1 | $1.38K | Sell |
301
-6,659
| -96% | -$30.4K | ﹤0.01% | 1982 |
|
|
2024
Q4 | $39.3K | Sell |
6,960
-899
| -11% | -$5.07K | ﹤0.01% | 1717 |
|
|
2024
Q3 | $38K | Sell |
7,859
-1,143,691
| -99% | -$5.54M | ﹤0.01% | 1695 |
|
|
2024
Q2 | $5.62M | Sell |
1,151,550
-2,405,027
| -68% | -$11.7M | 0.01% | 687 |
|
|
2024
Q1 | $47.2M | Sell |
3,556,577
-423,795
| -11% | -$5.63M | 0.11% | 234 |
|
|
2023
Q4 | $55.5M | Buy |
3,980,372
+1,448,003
| +57% | +$20.2M | 0.14% | 194 |
|
|
2023
Q3 | $33.6M | Buy |
2,532,369
+129,729
| +5% | +$1.72M | 0.09% | 262 |
|
|
2023
Q2 | $45M | Hold |
2,402,640
| – | – | 0.11% | 224 |
|
|
2023
Q1 | $34.6M | Buy |
2,402,640
+324,351
| +16% | +$4.68M | 0.09% | 266 |
|
|
2022
Q4 | $40.2M | Buy |
2,078,289
+328,552
| +19% | +$6.36M | 0.11% | 232 |
|
|
2022
Q3 | $60.1M | Buy |
1,749,737
+651,900
| +59% | +$22.4M | 0.18% | 145 |
|
|
2022
Q2 | $16.8M | Buy |
1,097,837
+387,600
| +55% | +$5.92M | 0.05% | 435 |
|
|
2022
Q1 | $16.2M | Buy |
710,237
+340,237
| +92% | +$7.76M | 0.04% | 492 |
|
|
2021
Q4 | $13.6M | Hold |
370,000
| – | – | 0.03% | 575 |
|
|
2021
Q3 | $17.4M | Hold |
370,000
| – | – | 0.03% | 509 |
|
|
2021
Q2 | $22.3M | Buy |
+370,000
| New | +$22.3M | 0.04% | 451 |
|